Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
Faculty Directory Administration Administrative Departments
border=0
| Home > Faculty & Administration >
Kathy Hormi-Carver

 
 
Faculty Directory
 
 
Find a Doctor
 
 
Faculty Research Interests
 
 
Search Help
 
 
Update Faculty ProfileAccessible on campus or vpn
 
 
 

Kathy Hormi-Carver, Ph.D.

 Details of Research

Biographical Sketch Details of Research Personal Overview How to Contact
Kathy Hormi-Carver
Name:
  Kathy Khadija Hormi-Carver, Ph.D.
Academic Title:
  Assistant Professor
Primary Appointment:
  Internal Medicine - Digestive and Liver Diseases
Secondary Appointment:
  Internal Medicine - Digestive and Liver Diseases
Department Website:
  Internal Medicine - Digestive and Liver Diseases

 RESEARCH OVERVIEW
 
Currently, resitance to apoptosis and implication of NF-?UB/STAT3 activation are two major research areas are being investigated extensively in Dr’s Hormi-Carver’s laboratory. Understanding the molecular mechanism of bile reflux in the neoplastic progression of Barrett!|s esophagus may lead to a change in our current management strategies for patients with this disease. Furthermore, identifying the molecular events triggered by bile reflux may allow for the development of specific chemopreventive agents to prevent progression to malignancy.
Dr. Hormi-Carver’s preliminary data demonstrate that compared to normal esophageal squamous cells, metaplastic Barrett!|s cells have minimal induction of p53 protein and apoptosis rates following exposure to UV-B suggesting that altered p53 expression, in response to DNA damage, contributes to the difference in apoptosis rates between esophageal squamous and metaplastic Barrett!|s mucosa. Metaplastic Barrett!|s epithelial cells were also found to have increased levels of, a very known protein implicated in conferring resistance to apoptosis, NF-?UB, suggesting that Barrett!|s metaplastic cells are resistant to the apoptosis normally induced by DNA damage, a feature that may underlie their malignant predisposition.
Dr. Hormi-Carver’s hypothesize that alterations in p53 expression and NF-?UB/STAT3 activation following bile acid exposure contribute to the apoptotic resistant phenotype of metaplastic Barrett!|s epithelial cells. To test this hypothese, she propose to investigate the effects of deoxycholic acid, a conjugated bile, on p53, anti-apoptotic proteins expression and on NF-?UB/STAT3 activation and also on the rates of apoptosis in normal esophageal squamous and metaplastic Barrett!|s epithelial cells in vitro.